Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Shingrix

- PMLiVE

GSK’s Witty ends on a high, but warns 2017 looking ‘uncertain’

Generic competition to big-selling Seretide/Advair in the US could accelerate sales decline

- PMLiVE

GSK hopes real-world data flu app will go viral

Flumji has been developed by MIT Connection Science

- PMLiVE

GSK’s Deborah Waterhouse to take over from ViiV’ Dominique Limet

She will become CEO designate at the HIV-focused firm in January

- PMLiVE

GSK files shingles vaccine Shingrix in Europe

Blockbuster hopeful would compete with Merck & Co’s Zostavax

- PMLiVE

GSK set for 2017 European rollout of med device asthma app

Updated version of the MyAsthma iPhone app is firm's first Class 1 med device

- PMLiVE

GSK starts late-stage trials of daprodustat

Drug hopes to treat anaemia caused by chronic kidney disease

- PMLiVE

GSK’s blockbuster hopeful Shingrix filed in US

Clinical data showed shingles vaccine had 90% efficacy in elderly patients

- PMLiVE

Pharma ramps up its use of Instagram

GSK became the latest firm to join the social network, signing up last month

- PMLiVE

GSK throws gauntlet down to Merck with shingles vaccine data

Shingrix trial reported ninety per cent efficacy in elderly patients who do not respond well to Zostavax

- PMLiVE

GSK and J&J file sirukumab for rheumatoid arthritis in EU

If approved it will compete with Roche blockbuster Actemra

- PMLiVE

GSK launches first pharma trial powered by Apple’s ResearchKit

Will use an iPhone app built using the software for a real-world study

- PMLiVE

GSK signs up for the ‘dawn of cognitive advertising’

Its consumer health arm is among the first to use new IBM offering Watson Ads

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links